Dave B. Hoon

Production of tumor necrosis factor α and interferon γ in interleukin-2-treated melanoma patients: Correlation with clinical toxicity

S. Swisher, D. Hoon, D. Morton, 2005, Cancer Immunology, Immunotherapy.

Ganglioside gm2 as a target structure recognized by human natural killer cells

P. Pattengale, S. Golub, I. Ando, 1987 .

Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma.

D. Morton, D. Hoon, C. Kuo, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2.

A. Cochran, D. Hoon, R. Irie, 1988, Cellular immunology.

Suppressor cell activity in a randomized trial of patients receiving active specific immunotherapy with melanoma cell vaccine and low dosages of cyclophosphamide.

D. Morton, D. Hoon, L. Foshag, 1990, Cancer research.